262 related articles for article (PubMed ID: 32568474)
21. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
[TBL] [Abstract][Full Text] [Related]
22. Minimal Hepatic Encephalopathy in Patients with Alcohol Related and Non-alcoholic Steatohepatitis Related Cirrhosis by Psychometric Hepatic Cephalopathy Score and Critical Flicker Frequency.
Jagtap N; Bhakhar P; Miftahussurur M; S YH; Shrimal P; Sharma M; Gupta R; Rao PN; Reddy DN
Acta Med Indones; 2021 Jan; 53(1):24-30. PubMed ID: 33818404
[TBL] [Abstract][Full Text] [Related]
23. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
[TBL] [Abstract][Full Text] [Related]
24. Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
Kaps L; Hildebrand K; Nagel M; Michel M; Kremer WM; Hilscher M; Galle PR; Schattenberg JM; Wörns MA; Labenz C
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101873. PubMed ID: 35124289
[TBL] [Abstract][Full Text] [Related]
25. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach.
Greinert R; Ripoll C; Hollenbach M; Zipprich A
Aliment Pharmacol Ther; 2016 Sep; 44(5):514-21. PubMed ID: 27385440
[TBL] [Abstract][Full Text] [Related]
26. The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
Campagna F; Montagnese S; Ridola L; Senzolo M; Schiff S; De Rui M; Pasquale C; Nardelli S; Pentassuglio I; Merkel C; Angeli P; Riggio O; Amodio P
Hepatology; 2017 Jul; 66(1):198-208. PubMed ID: 28271528
[TBL] [Abstract][Full Text] [Related]
27. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
[TBL] [Abstract][Full Text] [Related]
28. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.
Özbaş B; Keskin O; Hecker H; Karahan I; Özbaş C; Kalkan Ç; Kartal A; Önder FO; Öncü BK; Gençdal G; Akyildiz M; Günşar F; Idilman R; Weissenborn K; Özütemiz Ö; Yurdaydin C
Hepatol Int; 2021 Dec; 15(6):1442-1455. PubMed ID: 34085147
[TBL] [Abstract][Full Text] [Related]
29. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study.
Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Gabriel M; Ehrenbauer AF; Bloom PP; Ripoll C; Sultanik P; Galle PR; Labenz J; Thabut D; Zipprich A; Lok AS; Weissenborn K; Marquardt JU; Lauridsen MM; Nardelli S; Montagnese S; Labenz C
Am J Gastroenterol; 2023 Dec; 118(12):2191-2200. PubMed ID: 36940426
[TBL] [Abstract][Full Text] [Related]
31. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
[TBL] [Abstract][Full Text] [Related]
32. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
Hu XP; Gao J
World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C
Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111
[TBL] [Abstract][Full Text] [Related]
34. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
[TBL] [Abstract][Full Text] [Related]
35. Animal naming test for the assessment of minimal hepatic encephalopathy in Asian cirrhotic populations.
Qu Y; Li T; Lin C; Liu F; Wu S; Wang L; Ye Q
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101729. PubMed ID: 34091081
[TBL] [Abstract][Full Text] [Related]
36. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
[TBL] [Abstract][Full Text] [Related]
37. Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
Acharya C; Nadhem O; Shaw J; Hassouneh R; Fagan A; McGeorge S; Sterling RK; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles HS; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
Am J Gastroenterol; 2021 Dec; 116(12):2385-2389. PubMed ID: 34140445
[TBL] [Abstract][Full Text] [Related]
38. [Impact of different diagnostic criteria for assessing mild micro-hepatic encephalopathy in liver cirrhosis: an analysis based on a prospective, multicenter, real-world study].
Li XY; Liu SH; Liu C; Zu HM; Guo XQ; Xiang HL; Huang Y; Yan ZL; Li YJ; Sun J; Song RX; Yan JQ; Ye Q; Liu F; Huang L; Meng FP; Zhang XN; Yang SS; Hu SJ; Ruan JG; Li YL; Wang NN; Cui HP; Wang YM; Lei C; Wang QH; Tian HL; Qu ZS; Yuan M; Shi RC; Yang XT; Jin D; Su D; Liu YJ; Chen Y; Xia YX; Li YZ; Yang QH; Li H; Zhao XL; Tian ZM; Yu HJ; Zhang XJ; Wu CX; Wu ZJ; Li SS; Shen Q; Liu XM; Hu JP; Wu MQ; Dang T; Wang J; Meng XM; Wang HY; Jiang ZY; Liu YY; Liu Y; Qu SX; Tao H; Yan DM; Liu J; Fu W; Yu J; Wang FS; Qi XL; Fu JL
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):961-968. PubMed ID: 37872092
[No Abstract] [Full Text] [Related]
39. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.
Taneja S; Dhiman RK; Khatri A; Goyal S; Thumbru KK; Agarwal R; Duseja A; Chawla Y
J Clin Exp Hepatol; 2012 Dec; 2(4):306-14. PubMed ID: 25755452
[TBL] [Abstract][Full Text] [Related]
40. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
